UltraSight AI
Ultra Sight AI is an innovative healthcare technology company that specializes in AI-powered cardiac ultrasound solutions. Their software provides real-time guidance and quality assessment, enabling healthcare professionals of varying expertise to perform diagnostic-quality cardiac ultrasound exams. With FDA clearance and proven clinical validation, Ultra Sight AI has demonstrated a remarkable 95% accuracy in diagnostics and has successfully scanned over 30,000 patients. The company aims to simplify cardiac imaging, expand patient access to timely care, and improve outcomes through advanced AI technology, making it a strong player in the healthcare technology market.
UltraSight AI
Ultra Sight AI is an innovative healthcare technology company that specializes in AI-powered cardiac ultrasound solutions. Their software provides real-time guidance and quality assessment, enabling healthcare professionals of varying expertise to perform diagnostic-quality cardiac ultrasound exams. With FDA clearance and proven clinical validation, Ultra Sight AI has demonstrated a remarkable 95% accuracy in diagnostics and has successfully scanned over 30,000 patients. The company aims to simplify cardiac imaging, expand patient access to timely care, and improve outcomes through advanced AI technology, making it a strong player in the healthcare technology market.
TL;DR
What they do: AI-powered cardiac ultrasound software that provides real-time guidance and quality assessment for diagnostic‑quality exams
Regulatory / clinical signals: FDA clearance; clinical validation reporting ~95% diagnostic accuracy and >30,000 patients scanned
Founded / HQ: Founded 2019 — New York, NY
Funding: Seed-stage company; reported total funding ~1760000.00 USD
Notable investor signal: Dealroom lists SELVAS Healthcare as an investor; Dealroom shows Yozma Group, Atain Specialty Insurance Company, and Weizmann Institute of Science as exited investors
Company Overview
Problem Domain
Improve access to and accuracy of cardiac ultrasound imaging to enable faster, more reliable clinical decisions.
Founded
2019
Industry
Healthcare technology
Funding Track Record
Investor Signal
“Investors shown include SELVAS Healthcare; Dealroom lists Yozma Group, Atain Specialty Insurance Company, and Weizmann Institute of Science as exited investors.”